Logo image of HTGM

HTG MOLECULAR DIAGNOSTICS (HTGM) Stock Price, Quote, News and Overview

NASDAQ:HTGM - Nasdaq - US40434H3021 - Common Stock - Currency: USD

0.48  -0.12 (-20%)

After market: 0.4815 +0 (+0.31%)

HTGM Quote, Performance and Key Statistics

HTG MOLECULAR DIAGNOSTICS

NASDAQ:HTGM (6/14/2023, 8:00:02 PM)

After market: 0.4815 +0 (+0.31%)

0.48

-0.12 (-20%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High24.96
52 Week Low0.46
Market Cap1.06M
Shares2.21M
Float2.12M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-09 2023-08-09/amc
IPO05-06 2015-05-06


HTGM short term performance overview.The bars show the price performance of HTGM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

HTGM long term performance overview.The bars show the price performance of HTGM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of HTGM is 0.48 USD. In the past month the price decreased by -81.32%. In the past year, price decreased by -92.79%.

HTG MOLECULAR DIAGNOSTICS / HTGM Daily stock chart

HTGM Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 36.13 36.66B
DOCS DOXIMITY INC-CLASS A 56.54 13.58B
WAY WAYSTAR HOLDING CORP N/A 7.26B
CERT CERTARA INC 33.77 2.12B
TDOC TELADOC HEALTH INC N/A 1.98B
GDRX GOODRX HOLDINGS INC-CLASS A 15.03 1.83B
SDGR SCHRODINGER INC N/A 1.65B
PHR PHREESIA INC N/A 1.64B
EVH EVOLENT HEALTH INC - A 15.8 1.22B
HSTM HEALTHSTREAM INC 50.58 999.88M
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 966.46M
DH DEFINITIVE HEALTHCARE CORP 14.47 762.50M

About HTGM

Company Profile

HTGM logo image HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. The company is headquartered in Tucson, Arizona and currently employs 53 full-time employees. The company went IPO on 2015-05-06. The firm is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The firm is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and from sample processing services. Its HTG EdgeSeq profiling technology measures ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) nuclease protection probes (DNA protection probes). Its profiling product and service solutions enable targeted RNA profiling using a small amount of biological sample, in liquid or solid forms. Its menu of HTG EdgeSeq assays includes the HTG Transcriptome Panel (HTP), which is designed to measure approximately 20,000 mRNA targets using its HTG EdgeSeq technology, is automated on its HTG EdgeSeq system.

Company Info

HTG MOLECULAR DIAGNOSTICS

3430 E Global Loop

Tucson ARIZONA 85706 US

CEO: John L. Lubniewski

Employees: 53

Company Website: https://www.htgmolecular.com/

Phone: 18772892615.0

HTG MOLECULAR DIAGNOSTICS / HTGM FAQ

What is the stock price of HTG MOLECULAR DIAGNOSTICS today?

The current stock price of HTGM is 0.48 USD. The price decreased by -20% in the last trading session.


What is the ticker symbol for HTG MOLECULAR DIAGNOSTICS stock?

The exchange symbol of HTG MOLECULAR DIAGNOSTICS is HTGM and it is listed on the Nasdaq exchange.


On which exchange is HTGM stock listed?

HTGM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for HTG MOLECULAR DIAGNOSTICS stock?

7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48. Check the HTG MOLECULAR DIAGNOSTICS stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is HTG MOLECULAR DIAGNOSTICS worth?

HTG MOLECULAR DIAGNOSTICS (HTGM) has a market capitalization of 1.06M USD. This makes HTGM a Nano Cap stock.


How many employees does HTG MOLECULAR DIAGNOSTICS have?

HTG MOLECULAR DIAGNOSTICS (HTGM) currently has 53 employees.


Is HTG MOLECULAR DIAGNOSTICS (HTGM) expected to grow?

The Revenue of HTG MOLECULAR DIAGNOSTICS (HTGM) is expected to grow by 0.6% in the next year. Check the estimates tab for more information on the HTGM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HTG MOLECULAR DIAGNOSTICS (HTGM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HTG MOLECULAR DIAGNOSTICS (HTGM) stock pay dividends?

HTGM does not pay a dividend.


When does HTG MOLECULAR DIAGNOSTICS (HTGM) report earnings?

HTG MOLECULAR DIAGNOSTICS (HTGM) will report earnings on 2023-08-09, after the market close.


What is the Price/Earnings (PE) ratio of HTG MOLECULAR DIAGNOSTICS (HTGM)?

HTG MOLECULAR DIAGNOSTICS (HTGM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.15).


HTGM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

HTGM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to HTGM. Both the profitability and financial health of HTGM have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HTGM Financial Highlights

Over the last trailing twelve months HTGM reported a non-GAAP Earnings per Share(EPS) of -18.15. The EPS increased by 44.99% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 7.1
Chartmill High Growth Momentum
EPS Q2Q%76.54%
Sales Q2Q%-12.83%
EPS 1Y (TTM)44.99%
Revenue 1Y (TTM)-28.21%

HTGM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to HTGM. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 81.55% and a revenue growth 0.6% for HTGM


Ownership
Inst Owners0%
Ins Owners201.96%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.86
Price Target6.12 (1175%)
EPS Next Y81.55%
Revenue Next Year0.6%